NCCN Adds ImmunityBio’s Anktiva to Bladder Cancer Guidelines
Mar 23, 2026
View online
NCCN Adds ImmunityBio’s Anktiva to Bladder Cancer Guidelines
Global Cardio-Oncology Summit (GC-OS) 2026
Novartis Bets $2B on Mutant-Selective PI3Kα Inhibitor to Revive Triple Therapy in Breast Cancer
10 Articles Suggested by Vivek Subbiah
10 Must-Read Posts In GI Oncology This Week
Robotic Bronchoscopy and G20 Pulsed Electric Field Ablation: Two Breakthroughs Reshaping Lung Cancer Care
Sacituzumab Govitecan Plus Pembrolizumab Improves First-Line Outcomes in PD-L1 Positive Advanced Triple-Negative Breast Cancer
OCRA Collaborative Research Development Grant – Microsoft AI for Good Lab (2027)
CPRIT Individual Investigator Research Awards for Computational and Systems Biology of Cancer (IIRACSBC) (FY2027)
CPRIT Individual Investigator Research Awards for Cancer in Children and Adolescents (IIRACCA) (FY2027)
CPRIT Individual Investigator Research Awards for Clinical Trials (IIRACT) (FY2027)
NCCN 2026 Oncology Fellows Program: New Horizons in Quality Cancer Care
2026 Japanese Society of Medical Oncology Annual Meeting
NCCN 2026 Nursing Program: Advancing Oncology Nursing
Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
